Cash flow Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 14/09/2024 am IST			5-day change	1st Jan Change
116.00 ^USD	+1.64%		+3.96%	+84.71%

10/09	Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree...
10/09	Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating	MT

9ff.Agsk4ls4EBIWgNe4PbDF4MU-azi0cma9XhUhmPcV0sg.Q3JssgR8dndz8JbpZ4O1uIkMPFCHJiL4ZmRZ6qRRs5lrflOYAWtTXS6zjg

Published financial data: VAXCYTE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Cost of Goods Sold, Total	-	-	-	2.3Cr	7.5Cr
Gross Profit	-	-	-	-2.3Cr	-7.5Cr
Selling General & Admin Expenses, Total	85.46L	1.6Cr	2.53Cr	3.98Cr	6.07Cr
R&D Expenses	4.56Cr	7.36Cr	7.84Cr	17Cr	33Cr
Other Operating Expenses, Total	5.42Cr	8.96Cr	10Cr	21Cr	39Cr
Operating Income	-5.42Cr	-8.96Cr	-10Cr	-23Cr	-47Cr
Interest Expense, Total	-40T	-7T	-7T	-2T	-
Interest And Investment Income	6L	2L	3L	83.56L	6.29Cr
Net Interest Expenses	6L	2L	3L	83.54L	6.29Cr
Currency Exchange Gains (Loss)	-1L	-23.51L	16.69L	-14.7L	-18.97L
Other Non Operating Income (Expenses)	2L	24.78L	15.85L	19.31L	47.65L
EBT, Excl. Unusual Items	-5.35Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Gain (Loss) On Sale Of Investments	-	-	2T	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-44T	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	31.85L	-	-	-	-
EBT, Incl. Unusual Items	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Earnings From Continuing Operations	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Net Income to Company	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Net Income - (IS)	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Net Income to Common Incl Extra Items	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Net Income to Common Excl. Extra Items	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Per Share Items
Net EPS - Basic	-13.25	-3.02	-1.93	-3.44	-4.14
Basic EPS - Continuing Operations	-13.25	-3.02	-1.93	-3.44	-4.14
Basic Weighted Average Shares Outstanding	37.95L	2.95Cr	5.19Cr	6.49Cr	9.72Cr
Net EPS - Diluted	-13.25	-3.02	-1.93	-3.44	-4.14
Diluted EPS - Continuing Operations	-13.25	-3.02	-1.93	-3.44	-4.14
Diluted Weighted Average Shares Outstanding	37.95L	2.95Cr	5.19Cr	6.49Cr	9.72Cr
Normalized Basic EPS	-8.8	-1.89	-1.2	-2.15	-2.59
Normalized Diluted EPS	-8.8	-1.89	-1.2	-2.15	-2.59
Supplemental Items
EBITDA	-5.29Cr	-8.82Cr	-10Cr	-23Cr	-46Cr
EBITA	-5.42Cr	-8.96Cr	-10Cr	-23Cr	-47Cr
EBIT	-5.42Cr	-8.96Cr	-10Cr	-23Cr	-47Cr
EBITDAR	-5.23Cr	-8.75Cr	-9.87Cr	-22Cr	-46Cr
Normalized Net Income	-3.34Cr	-5.58Cr	-6.25Cr	-14Cr	-25Cr
Interest on Long-Term Debt	40T	7T	7T	2T	-
Supplemental Operating Expense Items
General and Administrative Expenses	85.46L	1.6Cr	2.53Cr	3.98Cr	6.07Cr
Research And Development Expense From Footnotes	4.56Cr	7.36Cr	7.84Cr	17Cr	33Cr
Net Rental Expense, Total	6L	7L	32L	79L	85L
Imputed Operating Lease Interest Expense	1L	-	-	7.27T	-
Imputed Operating Lease Depreciation	5L	-	-	78.93L	-
Stock-Based Comp., R&D Exp. (Total)	4L	18.61L	39.54L	98.99L	2.33Cr
Stock-Based Comp., G&A Exp. (Total)	8L	35.73L	67.75L	1.38Cr	2.55Cr
Total Stock-Based Compensation	11.85L	54.34L	1.07Cr	2.36Cr	4.88Cr

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	5.9Cr	39Cr	6.9Cr	83Cr	40Cr
Short Term Investments	-	-	18Cr	9.67Cr	68Cr
Total Cash And Short Term Investments	5.9Cr	39Cr	25Cr	93Cr	108.02Cr
Other Receivables	-	3L	12L	10L	36.07L
Total Receivables	-	3L	12L	10L	36.07L
Prepaid Expenses	27.47L	25.04L	91.78L	1.02Cr	61.59L
Other Current Assets, Total	-	-	-	-	59.61L
Total Current Assets	6.17Cr	39Cr	26Cr	94Cr	109.6Cr
Gross Property Plant And Equipment	63.73L	73.69L	4.11Cr	3.78Cr	12Cr
Accumulated Depreciation	-29.82L	-40.97L	-52.05L	-61.17L	-92.72L
Net Property Plant And Equipment	33.91L	32.72L	3.59Cr	3.16Cr	11Cr
Long-term Investments	-	-	2.71Cr	2.65Cr	16Cr
Deferred Charges Long-Term	-	1L	5L	-	-
Other Long-Term Assets, Total	6L	4L	44.6L	54.26L	3.87Cr
Total Assets	6.57Cr	39Cr	32Cr	100.62Cr	140.79Cr
Liabilities
Accounts Payable, Total	33.76L	2.98Cr	67.58L	97.95L	1.46Cr
Accrued Expenses, Total	74.96L	1.71Cr	1.67Cr	2.48Cr	12Cr
Current Portion of Leases	2L	-	52.76L	59.1L	71.13L
Other Current Liabilities	19T	14T	-	-	-
Total Current Liabilities	1.11Cr	4.69Cr	2.87Cr	4.05Cr	15Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	1.15Cr	1.2Cr	2.21Cr
Other Non Current Liabilities	3L	1L	96T	9T	-
Total Liabilities	1.13Cr	4.7Cr	4.03Cr	5.26Cr	17Cr
Preferred Stock Convertible	16Cr	-	-	-	-
Preferred Stock - Others	4L	-	-	-	-
Total Preferred Equity	16Cr	-	-	-	-
Common Stock, Total	7T	54T	56T	82T	98T
Additional Paid In Capital	29.67L	54Cr	58Cr	147.6Cr	216.46Cr
Retained Earnings	-11Cr	-20Cr	-30Cr	-52Cr	-92Cr
Comprehensive Income and Other	-	-	-2L	-4L	2L
Total Common Equity	-11Cr	35Cr	28Cr	95Cr	124.05Cr
Total Equity	5.44Cr	35Cr	28Cr	95Cr	124.05Cr
Total Liabilities And Equity	6.57Cr	39Cr	32Cr	100.62Cr	140.79Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40.6L	5.13Cr	5.63Cr	8Cr	11Cr
ECS Total Common Shares Outstanding	40.6L	5.11Cr	5.3Cr	7.95Cr	9.54Cr
Book Value / Share	-26.2	6.77	5.36	12	13.01
Tangible Book Value	-11Cr	35Cr	28Cr	95Cr	124.05Cr
Tangible Book Value Per Share	-26.2	6.77	5.36	12	13.01
Total Debt	2L	0	1.68Cr	1.79Cr	2.92Cr
Net Debt	-5.88Cr	-39Cr	-23Cr	-91Cr	-105.1Cr
Debt Equivalent Oper. Leases	48L	56L	2.56Cr	6.32Cr	6.8Cr
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	38.03L	52.47L	1.15Cr	1.51Cr	3.56Cr
Full Time Employees	-	58	89	158	254
Assets under Capital Lease - Gross	7L	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-5.03Cr	-8.92Cr	-10Cr	-22Cr	-40Cr
Depreciation & Amortization - CF	12.32L	14.05L	34.57L	91.96L	1.02Cr
Depreciation & Amortization, Total	12.32L	14.05L	34.57L	91.96L	1.02Cr
(Gain) Loss From Sale Of Asset	1T	34T	97T	44T	-
(Gain) Loss on Sale of Investments - (CF)	-	-	14.06L	-9L	-3.48Cr
Asset Writedown & Restructuring Costs	-	3L	-	2L	-
Stock-Based Compensation (CF)	11.85L	54.34L	1.07Cr	2.36Cr	4.88Cr
Other Operating Activities, Total	-31.97L	2L	-	79.95L	-
Change In Accounts Payable	9L	2.61Cr	-1.25Cr	28.96L	1.12Cr
Change in Other Net Operating Assets	30.4L	91.68L	-2.45Cr	98.41L	7.01Cr
Cash from Operations	-4.71Cr	-4.66Cr	-12Cr	-17Cr	-30Cr
Capital Expenditure	-11.95L	-11.55L	-65.55L	-58.48L	-6.79Cr
Sale of Property, Plant, and Equipment	-	50T	26T	7T	-
Investment in Marketable and Equity Securities, Total	-	-	-21Cr	8.04Cr	-71Cr
Cash from Investing	-11.95L	-11.05L	-21Cr	7.46Cr	-77Cr
Long-Term Debt Repaid, Total	-3L	-61T	-	-	-
Total Debt Repaid	-3L	-61T	-	-	-
Issuance of Common Stock	4L	27Cr	1.78Cr	86Cr	64Cr
Issuance of Preferred Stock	4.25Cr	11Cr	-	-	-
Other Financing Activities, Total	-10.97L	-34.89L	-	-9L	-38.76L
Cash from Financing	4.16Cr	37Cr	1.78Cr	86Cr	64Cr
Foreign Exchange Rate Adjustments	-3L	87T	-4L	1L	-66.86L
Net Change in Cash	-71.14L	33Cr	-32Cr	77Cr	-44Cr
Supplemental Items
Cash Interest Paid	40T	7T	7T	2T	-
Levered Free Cash Flow	-3.03Cr	-1.44Cr	-8.82Cr	-11Cr	-20Cr
Unlevered Free Cash Flow	-3.03Cr	-1.44Cr	-8.82Cr	-11Cr	-20Cr
Change In Net Working Capital	-23.06L	-3.59Cr	3.1Cr	-1.04Cr	-9.91Cr
Net Debt Issued / Repaid	-3L	-61T	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-49.59	-24.42	-18.07	-21.82	-24.23
Return on Total Capital	-57.01	-27.97	-20.04	-22.82	-26.1
Return On Equity %	-87.49	-44.58	-31.78	-36.11	-36.67
Return on Common Equity	61.27	-74.51	-31.78	-36.11	-36.67
Short Term Liquidity
Current Ratio	5.58	8.3	8.93	23.26	7.54
Quick Ratio	5.34	8.25	8.61	23.01	7.46
Operating Cash Flow to Current Liabilities	-4.27	-1	-4.23	-4.21	-2.04
Average Days Payable Outstanding	-	-	-	131.37	59.33
Long Term Solvency
Total Debt/Equity	0.3	-	5.91	1.88	2.36
Total Debt / Total Capital	0.3	-	5.58	1.85	2.3
LT Debt/Equity	-	-	4.05	1.26	1.78
Long-Term Debt / Total Capital	-	-	3.83	1.24	1.74
Total Liabilities / Total Assets	17.22	11.96	12.43	5.22	11.89
EBIT / Interest Expense	-1.35T	-12.8T	-14.81T	-1L	-
EBITDA / Interest Expense	-1.32T	-12.6T	-14.1T	-1L	-
(EBITDA - Capex) / Interest Expense	-1.35T	-12.76T	-15.03T	-1L	-
Total Debt / EBITDA	-0	-	-0.17	-0.08	-0.06
Net Debt / EBITDA	1.11	4.38	2.32	4.12	2.3
Total Debt / (EBITDA - Capex)	-0	-	-0.16	-0.08	-0.06
Net Debt / (EBITDA - Capex)	1.09	4.32	2.18	4.01	2
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-	-	-	226.16
EBITDA, 1 Yr. Growth %	53.41	66.62	15.53	125.46	102.41
EBITA, 1 Yr. Growth %	52.4	65.42	15.73	124.03	101.52
EBIT, 1 Yr. Growth %	52.4	65.42	15.73	124.03	101.52
Earnings From Cont. Operations, 1 Yr. Growth %	70.51	77.46	12.17	123.31	80
Net Income, 1 Yr. Growth %	70.51	77.46	12.17	123.31	80
Normalized Net Income, 1 Yr. Growth %	54.22	66.89	12.17	123.26	80.03
Diluted EPS Before Extra, 1 Yr. Growth %	63.58	-77.21	-36.17	78.72	20.19
Net Property, Plant and Equip., 1 Yr. Growth %	-0.59	-3.51	997.56	-11.87	249.54
Total Assets, 1 Yr. Growth %	-7.21	497.93	-17.44	210.23	39.93
Tangible Book Value, 1 Yr. Growth %	84.27	-425.12	-17.88	235.76	30.08
Common Equity, 1 Yr. Growth %	84.27	-425.12	-17.88	235.76	30.08
Cash From Operations, 1 Yr. Growth %	54.75	-1.1	160.34	40.53	73.97
Capital Expenditures, 1 Yr. Growth %	-32.64	-3.35	467.53	-10.79	1.06T
Levered Free Cash Flow, 1 Yr. Growth %	50.39	-52.56	512.43	22.26	87.78
Unlevered Free Cash Flow, 1 Yr. Growth %	50.62	-52.53	512.58	22.27	87.78
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	75.37	59.88	38.74	61.39	113.62
EBITA, 2 Yr. CAGR %	74.26	58.78	38.36	61.02	112.48
EBIT, 2 Yr. CAGR %	74.26	58.78	38.36	61.02	112.48
Earnings From Cont. Operations, 2 Yr. CAGR %	70.78	73.95	41.09	58.27	100.49
Net Income, 2 Yr. CAGR %	70.78	73.95	41.09	58.27	100.49
Normalized Net Income, 2 Yr. CAGR %	73.9	60.43	36.82	58.26	100.49
Diluted EPS Before Extra, 2 Yr. CAGR %	65.53	-39.03	-61.86	6.81	46.56
Net Property, Plant and Equip., 2 Yr. CAGR %	6.82	-2.06	225.43	211	75.51
Total Assets, 2 Yr. CAGR %	28.75	135.55	122.19	60.04	108.35
Tangible Book Value, 2 Yr. CAGR %	91.09	144.76	63.4	66.05	108.99
Common Equity, 2 Yr. CAGR %	91.09	144.76	63.4	66.05	108.99
Cash From Operations, 2 Yr. CAGR %	77.5	23.71	60.46	91.28	56.36
Capital Expenditures, 2 Yr. CAGR %	-1.11	-19.31	134.21	125.02	221.79
Levered Free Cash Flow, 2 Yr. CAGR %	-	-15.53	70.46	173.64	51.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-15.45	70.52	173.68	51.53
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	72.4	43.47	63.12	74.05
EBITA, 3 Yr. CAGR %	-	71.26	42.89	62.47	73.52
EBIT, 3 Yr. CAGR %	-	71.26	42.89	62.47	73.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-	72.98	50.28	64.43	65.2
Net Income, 3 Yr. CAGR %	-	72.98	50.28	64.43	65.2
Normalized Net Income, 3 Yr. CAGR %	-	71.53	42.39	61.08	65.2
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-14.52	-38.09	-36.17	11.1
Net Property, Plant and Equip., 3 Yr. CAGR %	-	3.26	119.17	110.54	223.35
Total Assets, 3 Yr. CAGR %	-	114.81	66.08	148.34	53.04
Tangible Book Value, 3 Yr. CAGR %	-	128.13	70.08	107.74	53.07
Common Equity, 3 Yr. CAGR %	-	128.13	70.08	107.74	53.07
Cash From Operations, 3 Yr. CAGR %	-	46.06	58.54	53.52	85.33
Capital Expenditures, 3 Yr. CAGR %	-	-1.86	54.6	69.78	288.79
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	63.49	52.58	141.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	63.61	52.62	141.39
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	67.91	68.23
EBITA, 5 Yr. CAGR %	-	-	-	67.09	67.47
EBIT, 5 Yr. CAGR %	-	-	-	67.09	67.47
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	66.94	68.65
Net Income, 5 Yr. CAGR %	-	-	-	66.94	68.65
Normalized Net Income, 5 Yr. CAGR %	-	-	-	66.09	63.28
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-6.56	-12.61
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	60.49	100.54
Total Assets, 5 Yr. CAGR %	-	-	-	90.95	81.85
Tangible Book Value, 5 Yr. CAGR %	-	-	-	100.91	84.69
Common Equity, 5 Yr. CAGR %	-	-	-	100.91	84.69
Cash From Operations, 5 Yr. CAGR %	-	-	-	62.7	57.66
Capital Expenditures, 5 Yr. CAGR %	-	-	-	36.77	107.28
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	58.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	58.66